- Home
- DXCM
DXCM
DexCom Inc.
as 11-15-2024 4:00pm EST
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 28.0B | IPO Year: | 2005 |
| Target Price: | $101.29 | AVG Volume (30 days): | 5.0M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.67 | EPS Growth: | 83.21 |
| 52 Week Low/High: | $62.34 - $142.00 | Next Earning Date: | 10-24-2024 |
| Revenue: | $3,954,000,000 | Revenue Growth: | 16.19% |
| Revenue Growth (this year): | 13.1% | Revenue Growth (next year): | 14.82% |
Stock Insider Trading Activity of DexCom Inc. (DXCM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Heller Bridgette P | DXCM | Director | Sep 16 '24 | Sell | $70.00 | 1,000 | $70,000.00 | 24,349 | |
| Sylvain Jereme M | DXCM | EVP, Chief Financal Officer | Sep 9 '24 | Sell | $69.15 | 746 | $51,585.90 | 84,274 | |
| Leach Jacob Steven | DXCM | EVP, Chief Operating Officer | Sep 9 '24 | Sell | $69.15 | 746 | $51,585.90 | 264,915 | |
| Stern Sadie | DXCM | EVP, Chief HR Officer | Sep 9 '24 | Sell | $69.15 | 426 | $29,457.90 | 75,451 | |
| Brown Michael Jon | DXCM | EVP, Chief Legal Officer | Aug 30 '24 | Sell | $70.00 | 686 | $48,020.00 | 65,636 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
DexCom, Inc. (DXCM): Among 12 High Growth Large Cap Stocks to Buy Now
Business Wire
3 days ago
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
Argus Research
5 days ago
DXCM: Raising target price to $59.00
Argus Research
5 days ago
DXCM: Raising target price to $56.00
Motley Fool
9 days ago
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
Argus Research
12 days ago
DXCM: Lowering target price to $54.00
Argus Research
12 days ago
DXCM: Lowering target price to $55.00
Insider Monkey
16 days ago
DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss
Compare DXCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.